文献速递腹部儿科影像MR

儿童克罗恩病MR小肠造影回肠末端动力的定量评估:一项可行性研究

Quantitative assessment of terminal ileum motility on MR enterography in Crohn disease: a feasibility study in children.
PubMed 文献 · Eur Radiol · 2020-08-24

回顾性分析25例儿童克罗恩病或未分类炎症性肠病患者的MR小肠造影动态图像,用经验证的动力算法定量回肠末端动力。回肠末端动力评分与组织病理活动度评分(eAIS)呈负相关(r=-0.58,p=0.004,N=23),与CDMI亦呈负相关(r=-0.42,p=0.037,N=25);活动性疾病动力评分更低(中位0.12 vs 0.21,p=0.020),而CDMI更高(中位5 vs 1,p=0.04)。与粪便钙卫蛋白无显著相关(r=-0.27,p=0.4)。

要点

  • 儿童克罗恩病回肠末端动力随组织病理炎症加重而降低,与成人研究结果一致。
  • 回肠末端动力评分与CDMI呈负相关,活动性疾病动力评分更低而CDMI更高。
  • 自由呼吸技术下MRI定量肠道动力评估在儿童中可行。

关键影像表现/征象

  • MR小肠造影回肠末端动力评分中位0.17 a.u.(IQR 0.12至0.25;范围0.05至0.55),CDMI中位3(IQR 0至5.5)。
  • 43%的患者为活动性疾病(eAIS > 0),eAIS中位评分0(IQR 0至2;范围0至5)。

诊断标准与关键数值

  • 回肠末端动力评分与eAIS呈负相关(r=-0.58,p=0.004,N=23)。
  • 回肠末端动力评分与CDMI呈负相关(r=-0.42,p=0.037,N=25)。
  • 活动性疾病动力评分更低(中位0.12 vs 0.21,p=0.020),CDMI更高(中位5 vs 1,p=0.04)。
  • 12例MR小肠造影3个月内行粪便钙卫蛋白检测的患者中,动力评分与粪便钙卫蛋白无显著相关(r=-0.27,p=0.4)。

临床应用与阅片要点

  • 儿童克罗恩病MR小肠造影可采用自由呼吸技术进行定量肠道动力评估。
  • 回肠末端动力降低可能提示组织病理炎症活动度增加,阅片时可结合动力评分与CDMI综合评估。
  • 定量肠道动力可能是儿童克罗恩病疗效的候选生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Investigate the relationship between quantified terminal ileal (TI) motility and histopathological activity grading, Crohn Disease MRI Index (CDMI) and faecal calprotectin.

METHODS: Retrospective review of children with Crohn disease or unclassified inflammatory bowel disease, who underwent MR enterography. Dynamic imaging for 25 patients (median age 12, range 5 to 16) was analysed with a validated motility algorithm. The TI motility score was derived. The primary reference standard was TI Endoscopic biopsy Assessment of Inflammatory Activity (eAIS) within 40 days of the MR enterography. Secondary reference standards: (1) the Crohn Disease MRI Index (CDMI) and (2) faecal calprotectin levels.

RESULTS: MR enterography median motility score was 0.17 a.u. (IQR 0.12 to 0.25; range 0.05 to 0.55), and median CDMI was 3 (IQR 0 to 5.5). Forty-three percent of patients had active disease (eAIS > 0) with a median eAIS score of 0 (IQR 0 to 2; range 0 to 5). The correlation between eAIS and motility was r = - 0.58 (p = 0.004, N = 23). Between CDMI and motility, r = - 0.42 (p = 0.037, N = 25). Motility score was lower in active disease (median 0.12 vs 0.21, p = 0.020) while CDMI was higher (median 5 vs 1, p = 0.04). In a subset of 12 patients with faecal calprotectin within 3 months of MR enterography, correlation with motility was r = - 0.27 (p = 0.4).

CONCLUSIONS: Quantified terminal ileum motility decreases with increasing histopathological abnormality in children with Crohn disease, reproducing findings in adults. TI motility showed a negative correlation with an MRI activity score but not with faecal calprotectin levels.

KEY POINTS: • It is feasible to perform MRI quantified bowel motility assessment in children using free-breathing techniques. • Bowel motility in children with Crohn disease decreases as the extent of intestinal inflammation increases. • Quantified intestinal motility may be a candidate biomarker for treatment efficacy in children with Crohn disease.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cococcioni L, Fitzke H, Menys A, et al. Quantitative assessment of terminal ileum motility on MR enterography in Crohn disease: a feasibility study in children. Eur Radiol. 2020. PMID: 32833090. doi:10.1007/s00330-020-07084-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。